Gene Therapy Market Set to Grow at a CAGR of 40.8% in the First Half of the Forecast Period
August 14, 2018
August 14, 2018
LONDON, England, Aug. 14 -- Visiongain, a independent media company, issued the following news release:
Visiongain' has launched a new pharma report Gene Therapy R&D and Revenue Forecasts 2017-2027 (https://www.visiongain.com/report/gene-therapy-rd-and-revenue-forecasts-2017-2027/): Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases.
The gene therapy market is still establishing itself and many opportunities are available to explore at the moment. . . .
Visiongain' has launched a new pharma report Gene Therapy R&D and Revenue Forecasts 2017-2027 (https://www.visiongain.com/report/gene-therapy-rd-and-revenue-forecasts-2017-2027/): Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases.
The gene therapy market is still establishing itself and many opportunities are available to explore at the moment. . . .